Literature DB >> 124122

Mortality and life-table in Down's syndrome.

J Oster, M Mikkelsen, A Nielsen.   

Abstract

The causes of death in 130 patients with Down's Syndrome and mortality rates from a material of 524 patients were tabulated; a life-table for the ages over 5 years was constructed. An overall death rate of 5-7 times the general population rate was found. No sex difference was observed. The excess mortality was expecially high for heart disease and respiratory disease. Also infectious diseases, others than pneumonia and tuberculosis, showed high mortality rates.

Entities:  

Mesh:

Year:  1975        PMID: 124122     DOI: 10.1111/j.1651-2227.1975.tb03842.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  37 in total

1.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

2.  The failures of success. 1977.

Authors:  Ernest M Gruenberg
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

3.  [Ingestion and NBT reduction capacity of polymorphonuclear leucocytes in trisomy 21 (author's transl)].

Authors:  C Eschenbach; B Büdenbender
Journal:  Klin Wochenschr       Date:  1976-12-01

4.  On the influence of age on immunity in Down's syndrome.

Authors:  R Seger; G Buchinger; J Ströder
Journal:  Eur J Pediatr       Date:  1977-01-26       Impact factor: 3.183

5.  Down's syndrome and the general practitioner.

Authors:  G Howells
Journal:  Occas Pap R Coll Gen Pract       Date:  1990-11

6.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

Review 7.  Prenatal screening in Jewish law.

Authors:  J Brown
Journal:  J Med Ethics       Date:  1990-06       Impact factor: 2.903

8.  Childhood deaths in Down's syndrome. Survival curves and causes of death from a total population study in Queensland, Australia, 1976 to 1985.

Authors:  J A Bell; J H Pearn; D Firman
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

9.  Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy.

Authors:  N Fujii; K Oguma; M Fujii; R Fukatsu; N Takahata; M Kitabatake
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

10.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.

Authors:  R Karttunen; T Nurmi; J Ilonen; H M Surcel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.